Evidence map›Paper›PMID 35504326›Full record

ArticleJournal of the American Medical Directors Association2022

Remote Infection Control Assessments of US Nursing Homes During the COVID-19 Pandemic, April to June 2020.

Maroya Spalding Walters, Christopher Prestel, Lucy Fike, Nijika Shrivastwa, Janet Glowicz, Isaac Benowitz, Sandra Bulens, Emily Curren, Hannah Dupont, Perrine Marcenac and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Medical Directors Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Ten sustainable steps infectious diseases professionals can take to mitigate the climate crisis.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Maroya Spalding WaltersDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: vii0@cdc.gov.
Christopher PrestelDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lucy FikeNorthrop Grumman Corporation, Falls Church, VA, USA.
Nijika ShrivastwaDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Janet GlowiczDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Isaac BenowitzDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Sandra BulensDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Emily CurrenDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Hannah DupontCDC COVID-19 Healthcare Infection Control Team, Atlanta, GA, USA.
Perrine MarcenacCDC COVID-19 Healthcare Infection Control Team, Atlanta, GA, USA.
Garrett MahonEagle Global Scientific, LLC, San Antonio, TX, USA.
Anne MoormanCDC COVID-19 Healthcare Infection Control Team, Atlanta, GA, USA.
Abimbola OgundimuDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lauren M WeilDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
David KuharDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ronda CochranDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Melissa SchaeferDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kara Jacobs SlifkaDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Alexander KallenDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Joseph F PerzDivision of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
CDC TeleICAR Team
Centers for Disease Control and Prevention · USCDC Foundation · USNorthrop Grumman (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNursing homes (NHs) provide care in a congregate setting for residents at high risk of severe outcomes from SARS-CoV-2 infection. In spring 2020, NHs were implementing new guidance to minimize SARS-CoV-2 spread among residents and staff.

objectiveTo assess whether telephone and video-based infection control assessment and response (TeleICAR) strategies could efficiently assess NH preparedness and help resolve gaps.

designWe incorporated Centers for Disease Control and Prevention COVID-19 guidance for NH into an assessment tool covering 6 domains: visitor restrictions; health care personnel COVID-19 training; resident education, monitoring, screening, and cohorting; personal protective equipment supply; core infection prevention and control (IPC); and communication to public health. We performed TeleICAR consultations on behalf of health departments. Adherence to each element was documented and recommendations provided to the facility. SETTING AND

participantsHealth department-referred NHs that agreed to TeleICAR consultation.

methodsWe assessed overall numbers and proportions of NH that had not implemented each infection control element (gap) and proportion of NH that reported making ≥1 change in practice following the assessment.

resultsDuring April 13 to June 12, 2020, we completed TeleICAR consultations in 629 NHs across 19 states. Overall, 524 (83%) had ≥1 implementation gap identified; the median number of gaps was 2 (interquartile range: 1-4). The domains with the greatest number of facilities with gaps were core IPC practices (428/625; 68%) and COVID-19 education, monitoring, screening, and cohorting of residents (291/620; 47%). CONCLUSIONS AND IMPLICATIONS: TeleICAR was an alternative to onsite infection control assessments that enabled public health to efficiently reach NHs across the United States early in the COVID-19 pandemic. Assessments identified widespread gaps in core IPC practices that put residents and staff at risk of infection. TeleICAR is an important strategy that leverages infection control expertise and can be useful in future efforts to improve NH IPC.

Indexed as

COVID-19HumansInfection ControlNursing HomesPandemicsSARS-CoV-2United Statesinfection controlnursing homeSARS-CoV-2

Identifiers

PMID35504326
PMCPMC8983607
OpenAlexW4225986509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.